Myeloid differentiation
protein 1(
MD1), also known as lymphocyte
antigen 86 (LY86), plays an important role in the
toll-like receptor 4 (TLR4) signaling pathway. Recent studies show that
MD1 is involved in regulating pressure overload-induced cardiac structural and
electrical remodeling. However, the effect of
MD1 on
myocardial ischemia-reperfusion (I/R) injury and I/R related
arrhythmia remains unknown. To further investigate that, the present study used MD1-knockout (MD1-KO) mice to study the role of
MD1 in regulating myocardial I/R injury and its electrophysiology. The results demonstrate that the loss of
MD1 led to a larger
infarct size, increased activity of cardiac injury markers, aggravated histological damage, worsened cardiac function and decreased survival rate after myocardial I/R. Meanwhile,
MD1 deficiency also aggravated inflammatory responses, promoted cardiomyocyte apoptosis and increased susceptibility to ventricular
arrhythmia in mice subjected to myocardial I/R. Furthermore, loss of
MD1 enhanced the activation of
toll-like receptor 4 (TLR4) /
nuclear factor kappa B (NF-κB) signaling pathway after myocardial I/R. Therefore, loss of
MD1 exacerbated myocardial I/R injury and increased the susceptibility to ventricular
arrhythmia, both of which are possibly related to the up-regulation of TLR4/NF-κB signaling pathway.